Market Place
Sourcing Support
Carnegie`s Generic Liothyronine Sodium Receives Approval in the U.S.
06 Feb 2024 //
FDA
Enforcement Report - Week of December 20, 2023
20 Dec 2023 //
FDA
Sun Pharma, Lupin recall drugs in US on manufacturing woes
18 Dec 2023 //
TIMES OF INDIA
Enforcement Report - Week of November 8, 2023
08 Nov 2023 //
FDA
ALTURiX acquires UK rights to Liothyronine
31 May 2022 //
PHARMACEUTICALMANUFACTURER
Zydus Cadila gets US FDA nod for Liothyronine Sodium Tablets
23 Jan 2021 //
EXPRESSPHARMA
Enforcement Report - Week of September 23, 2020
23 Sep 2020 //
FDA
Bioiberica Launches Natural Origin Thyroid API
21 Nov 2019 //
CONTRACT PHARMA
Enforcement Report - Week of December 19, 2018
19 Dec 2018 //
FDA
Foothills Professional Pharmacy Receives FDA Form 483
22 Nov 2018 //
FDA
Teva Pharms` Generic Liothyronine Sodium Receives Approval in US
01 Nov 2018 //
FDA
Enforcement Report - Week of October 24, 2018
24 Oct 2018 //
FDA
Enforcement Report - Week of August 29, 2018
29 Aug 2018 //
FDA
Chinese Thyroid Drug API Recalled in US Over Quality Concerns
21 Aug 2018 //
RAPS
FDA Alerts Drug Makers of a Recall of Porcine Thyroid API
20 Aug 2018 //
R&DMAG
FDA Recalls Thyroid Medications Due to Contamination Risk
17 Aug 2018 //
MENTAL FLOSS
Thyroid meds recall -Chinese manufacturer`s failed inspection causes recall
17 Aug 2018 //
CNBC
Thyroid drugs made with ingredient from banned Chinese plant recalled in U.S.
16 Aug 2018 //
FIERCE PHARMA
Enforcement Report - Week of December 6, 2017
06 Dec 2017 //
FDA
ABPI respond to CMA provisional ruling on pricing of liothyronine tablets
27 Nov 2017 //
ABPI
Concordia accused of overcharging NHS for thyroid drug
22 Nov 2017 //
PMLIVE
Envigo thyroid hormone assay meets OECD guidelines
23 Feb 2017 //
OUTSOURCING PHARMA
Kineta Presents Promising New Data on Novel Lassa Fever Antiviral
22 Apr 2016 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.